Synthesis and antitumor activity of some new N-substituted-sulfonyl, 1,2,4-triazole, N-substituted-benzylidene and pyrrole derivatives attached to 4-(benzo[d]thiazol-2-yl)benzohydrazide

Der Pharma Chemica

Volumn 3, Issue 6, 2011, Pages 293-306

  El Hamouly, Wageeh S ^a   Amin, Kamelia M ^b   El Assaly, Samy A ^a   El Meguid, Eman A Abd ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

1,2,4 triazole; 4 (benzo d thiazol 2 yl)benzohydrazide; Antibreast cancer activity; Indoline; N substituted benzylidene; N substitutedsulfonyl; O aminothiophenol; Pyrrole

Indexed keywords

4 (4 BENZOTHIAZOL 2 YL) N [2 (1,2,3,4,5, PENTAHYDROXYPENTYL) 4 OXOTHIAZOLIDIN 3 YL]BENZAMIDE; 4 (BENZO[D]THIAZOL 2 YL) N (4 METHYLPENTAN 2 YLIDENE)BENZOHYDRAZIDE; 4 (BENZO[D]THIAZOL 2 YL) N (4 OXOCYCLOHEXYLIDENE)BENZOHYDRAZIDE; 4 (BENZO[D]THIAZOL 2 YL) N CAMPHORSULFONYL BENZOHYDRAZIDE; 4 (BENZO[D]THIAZOL 2 YL) N SULFONYLBENZENE BENZOHYDRAZIDE; 4 (BENZO[D]THIAZOL 2 YL) N' 2,3,4,5 TETRAHYDROXY PENTYLIDENE BENZOHYDRAZIDE; 4 (BENZO[D]THIAZOL 2 YL) N' [2,3,4,5,6 PENTAHYDROXY HEXYLIDENE]BENZOHYDRAZIDE; 4 (BENZO[D]THIAZOL 2 YL)BENZOYL 4 (4 CHLOROPHENYL)SEMICARBAZIDE; 4 (BENZO[D]THIAZOL 2 YL)BENZOYL 4 PHENYLTHIOSEMICARBAZIDE; 4 [(BENZO[D]THIAZOL 2 YL) N (1,3 DIOXOISOINDOLIN 2 YL)]BENZAMIDE; 4 [(BENZO[D]THIAZOL 2 YL) N (2,5 DIOXO 2H PYRROL 1(5H) YL)]BENZAMIDE; 4 [(BENZO[D]THIAZOL 2 YL) N (2,5 DIOXOPYRROLIDIN 1 YL)]BENZAMIDE; 4 METHYLBENZOIC ACID N' (4 BENZOTHIAZOL 2 YL BENZOYL)HYDRAZIDE; 5 [4 (BENZO[D]THIAZOL 2 YL)PHENYL] 4 (4 CHLOROPHENYL) 2 METHYL 2H 1,2,4 TRIAZOL 3(4H) ONE; 5 [4 (BENZO[D]THIAZOL 2 YL)PHENYL] 4 (4 CHLOROPHENYL) 2H 1,2,4 TRIAZOL 3(4H) ONE; 5 [4 (BENZO[D]THIAZOL 2 YL)PHENYL] 4 PHENYL 2H 1,2,4 TRIAZOL 3(4H) THIONE; [[4 (BENZO[D]THIAZOL 2 YL)PHENYL] 3,5 DIMETHYL 1H PYRAZOL 1 YL]METHANONE; ANTINEOPLASTIC AGENT; BENZOIC ACID N' (4 BENZOTHIAZOL 2 YL BENZOYL)HYDRAZIDE; DOXORUBICIN; ETHYL 3 [3 [4 (BENZO[D]THIAZOL 2 YL)PHENYL] 4 (4 CHLOROPHENYL) 4,5 DIHYDRO 5 OXO 1,2,4 TRIAZOL 1 YL]PROPANOATE; ETHYL 3 [4 (BENZO[D]THIAZOL 2 YL)PHENYL] 4 (4 CHLOROPHENYL) 4,5 DIHYDRO 5 OXO 1,2,4 TRIAZOLE 1 CARBOXYLATE; N' (3,4 DIMETHOXYBENZYLIDENE) 4 (BENZO[D]THIAZOL 2 YL)BENZOHYDRAZIDE; N' (4 BENZYLIDENE) 4 (BENZO[D]THIAZOL 2 YL)BENZOHYDRAZIDE; N' (4 CYANOBENZYLIDENE) 4 (BENZO[D]THIAZOL 2 YL)BENZOHYDRAZIDE; N' (4 DIMETHYLAMINOBENZYLIDENE) 4 (BENZO[D]THIAZOL 2 YL)BENZOHYDRAZIDE; N' (4 FLUOROBENZYLIDENE) 4 (BENZO[D]THIAZOL 2 YL)BENZOHYDRAZIDE; N' (4 HYDROXY 3 METHOXYBENZYLIDENE) 4 (BENZO[D]THIAZOL 2 YL)BENZOHYDRAZIDE; N' (4 NITROBENZYLIDENE) 4 (BENZO[D]THIAZOL 2 YL)BENZOHYDRAZIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; ELECTROPHILICITY; IC 50; IN VITRO STUDY;

EID: 84855297206     PISSN: None     EISSN: 0975413X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. SP Gupta, Chem. Rev., 1994, 94, 1507-1513.
2. SEH Wageeh, MA Kamelia, MHA Eman and AAM Eman, Chinese J. Chem., 2009, 27, 1629-1633.
3. E Kashiyama, I Hutchinson, MS Chua, SF Stinson, LR Phillips, G Kaur, EA Sausville, TD Bradshaw, AD Westwell and MFG Stevenes, J. Med. Chem., 1999, 42, 4172-4179.
4. DF Shi, TD Bradshaw, S Wrigley, CJ McCall, P Lelieveld, I Fichtner and MFG Stevens, J. Med. Chem., 1996, 39, 3375-3383.
5. I Hutchinson, SA Jennings, BR Vishnuvajjala, AD Westwell and MFG Stevenes, J. Med. Chem., 2002, 45(3), 744-749.
6. CO Leong, M Gaskell, EA Martin, RT Heydon, PB Farmer, MC Bibby, PA Cooper, JA Double, TD Bradshaw and MFG. Stevens, British. J. Cancer, 2003, 88, 470-476.
7. LW Wattenberg, MA Page and JL Leong, Cancer Res., 1968, 28, 2539-2543.
8. I Hutchinson, TD Bradshaw, CS Matthews, MFG Stevens and AD Westwell, Bioorg. Med. Chem. Lett., 2003, 13, 471-476.
9. RDR Reis and EC Azevedo et al. Eur. J. Med. Chem., 2011, 46, 1448-1453.
10. HA Bhuva and SG Kini, J. Mol. Graph. Model., 2010, 29, 32-38.
11. RM Kumbhare, KV Kumar, MJ Ramaiah, T Dadmal, SNCVL Pushpavalli, D Mukhopadhyay, B Divya, TA Devi, U Kosurkar and M Pal-Bhadra, Eur. J. Med. Chem., 2011, 46, 4258-4264.
12. K Van derpoorten, H Ucar, G Andrei, R Snoeck, J Balzarini, E Declercq and JH Poupaert, Antivir. Chem. Chemother., 1999, 10(2), 87-94.
13. SR Nagarajan and GA DeCrescenzo et al. Bioorg. Med. Chem., 2003, 11, 4769-4775.
14. D Bhavsar and J Trivedi et al. Bioorg. Med. Chem. Lett., 2011, 21, 3443-3449.
15. S Bondock, W Fadaly and MA Metwally, Eur. J. Med. Chem., 2009, 44, 4813-4819.
16. NB Patel, IH Khan and SD Rajani, Eur. J. Med. Chem., 2010, 45, 4293-4298.
17. J Koci, V Klimesova, K waisser, J Kaustova, HM Dahse and U Mollmann, Bioorg. Med. Chem. Lett., 2002, 12, 3275-3263.
18. T Mase, H Arima, K Tomioka, T Yamada and K Murase, Eur. J. Med. Chem., 1988, 23, 335-342.
19. YR Lee, GH Jin, SM Lee, JW Park, JH Ryu, R Jeon and BH Park, Biochem. Biophys. Res. Comm., 2011, 408, 625-629.
20. JB Baell, PJ Duggan, SA Forsyth, RJ Lewis, YP Lok and CI Schroedu, Bioog. Med. Chem., 2004, 12, 4025-4029.
21. J Poupaert, P Carato and E Colacino, Curr. Med. Chem., 2005, 12, 877-883.
22. D Cressier, C Prouillac, P Hernandez, C Amourette, M Diserbo, C Lion and C Rima, Bioorg. Med. Chem., 2009, 17, 5275-5281.
23. P Yogeeswari, D Sriram, S Mehta, D Nigam, MM Kumar, S Murugesan and JP Stables, IL. Farmaco, 2005, 60, 1-5.
24. ND Amnerkar and KP Bhusari, Eur. J. Med. Chem., 2010, 45, 149-154.
25. GW Valentine and G Sanacora, Biochem. Pharm., 2009, 78, 431-437.
26. E Hockly and J Tse et al. Neurbiol. Dis., 2006, 21, 228-233.
27. M Yoshida, I Hayashi, T Agatsuma, Y Oda, F Tanzawa, S Iwasaki, K Koyama, H Furukawa, S Kurakata and Y Sugano, Bioorg. Med. Chem. Lett., 2005, 15, 3328-3334.
28. J Sun, X Pan, Z Dai and C Zhu, Tetra:Asymm., 2008, 19, 2451-2458.
29. CS Rouvier, JM Barret, CM Farrell, D Sharples, BT Hill and J Barbe, Eur. J. Med. Chem., 2004, 39, 1029-1034.
30. IF Nassar and SA El-Assaly, Der Pharm. Chem., 2011, 3(1), 229-233.
31. A Cansiz, M Koparir and A Demirdag, Molecules, 2004, 9, 204-210
32. S Ersan, S Nacak and R Berkem, IL Farmaco, 1998, 53, 773-779
33. S Sandra, Konstantinovic, K Agnes, CR Blaga and D Andrea, Chem. Indust. Chem. Eng. Quart., 2008, 14(1), 2734-2738.
34. JAR Hasanen, EI Ibrahim, MA E Zein, N Rezki and EH El-Ashry, J. Chem. Soc. Pak., 2008, 30(2), 276-282.
35. P Vicini, A Geronikaki, M Incerti, B Busonera, G Poni, CA Cabras and PL Colla, Bioorg. Med. Chem., 2003, 11, 4785-4791.
36. MAM Taha and SM El-Badry, J. Chin. Chem. Soc., 2006, 53, 1181-1186.
37. MA Mosselhi, MA Abdallah, NH Metwally, IA El-Desoky and LM Break, Arkivoc, 2009, XIV, 53-59
38. S Wang, G Wood, C Meades, G Griffiths, C Midgley, L McNae, C Mclnnes, S Anderson, W Jackson, M Mezna, R Yuill, M Walkinshaw and PM Fischer, Bioorg. Med. Chem. Lett., 2004, 14(16), 4237-4242.
39. B Li, MPA Lyle, G Chen, J Li, K Hu, L Tang, MAA Jamali and J Webster, Bioorg. Med. Chem., 2007, 15, 4601-4606.
40. F Liu, X Qian, J Cui, Y Xiao, R Zhang and G Li, Bioorg. Med. Chem., 2006, 14(13), 4639-4644.
41. LI Wang, JJ Li, ZB Zheng, HY Liu, GJ Du and S Li, Eur. J. Pharm., 2004, 502(1-2), 1-6.
42. SJ Tangeda and A Garlapati, Eur. J. Med. Chem., 2010, 45, 1435-1439.
43. AA Raj, R Raghunathan, MRS Kumari and N Raman, Bioorg. Med. Chem., 2003, 11, 407-412.
44. P Skehan, R Storeng, et al. J. Natl. Cancer Inst., 1990, 82, 1107-1112.